DOCSLIB.ORG

Substance Use and Addiction During Pregnancy: Identifying Unvoiced Needs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

SUBSTANCE USE AND ADDICTION DURING PREGNANCY: IDENTIFYING UNVOICED NEEDS JASSIN M. JOURIA, MD DR. JASSIN M. JOURIA IS A MEDICAL DOCTOR, PROFESSOR OF ACADEMIC MEDICINE, AND MEDICAL AUTHOR. HE GRADUATED FROM ROSS UNIVERSITY SCHOOL OF MEDICINE AND HAS COMPLETED HIS CLINICAL CLERKSHIP TRAINING IN VARIOUS TEACHING HOSPITALS THROUGHOUT NEW YORK, INCLUDING KING’S COUNTY HOSPITAL CENTER AND BROOKDALE MEDICAL CENTER, AMONG OTHERS. DR. JOURIA HAS PASSED ALL USMLE MEDICAL BOARD EXAMS, AND HAS SERVED AS A TEST PREP TUTOR AND INSTRUCTOR FOR KAPLAN. HE HAS DEVELOPED SEVERAL MEDICAL COURSES AND CURRICULA FOR A VARIETY OF EDUCATIONAL INSTITUTIONS. DR. JOURIA HAS ALSO SERVED ON MULTIPLE LEVELS IN THE ACADEMIC FIELD INCLUDING FACULTY MEMBER AND DEPARTMENT CHAIR. DR. JOURIA CONTINUES TO SERVES AS A SUBJECT MATTER EXPERT FOR SEVERAL CONTINUING EDUCATION ORGANIZATIONS COVERING MULTIPLE BASIC MEDICAL SCIENCES. HE HAS ALSO DEVELOPED SEVERAL CONTINUING MEDICAL EDUCATION COURSES COVERING VARIOUS TOPICS IN CLINICAL MEDICINE. RECENTLY, DR. JOURIA HAS BEEN CONTRACTED BY THE UNIVERSITY OF MIAMI/JACKSON MEMORIAL HOSPITAL’S DEPARTMENT OF SURGERY TO DEVELOP AN E- MODULE TRAINING SERIES FOR TRAUMA PATIENT MANAGEMENT. DR. JOURIA IS CURRENTLY AUTHORING AN ACADEMIC TEXTBOOK ON HUMAN ANATOMY & PHYSIOLOGY. Abstract All healthcare professionals involved in the prenatal care of women should be observant to the unvoiced needs of the pregnant patient. This includes ongoing evaluation of the expectant mother’s knowledge of labor and delivery, emotional state and health risks. Screening for the risk and the diagnosis of a substance use disorder during pregnancy, as well as correlating socioeconomic and other environmental stressors; and, treatment and follow-up of the mother’s recovery and the child’s development in utero and after birth are discussed. nursece4less.com nursece4less.com nursece4less.com nursece4less.com 1 Policy Statement This activity has been planned and implemented in accordance with the policies of NurseCe4Less.com and the continuing nursing education requirements of the American Nurses Credentialing Center's Commission on Accreditation for registered nurses. It is the policy of NurseCe4Less.com to ensure objectivity, transparency, and best practice in clinical education for all continuing nursing education (CNE) activities. Continuing Education Credit Designation This educational activity is credited for 3 hours. Nurses may only claim credit commensurate with the credit awarded for completion of this course activity. Statement of Learning Need Identifying existing risks during a woman’s prenatal appointment requires open communication between the clinician and patient regarding substance use, including tobacco use and alcohol consumption, and possibly domestic abuse. Health clinicians must recognize their role to identify the patient’s unvoiced needs. This includes discussing health risks of malnutrition, depression and domestic abuse, which are difficult subjects for women to discuss if not approached carefully by a clinician using compassionate therapeutic communication. nursece4less.com nursece4less.com nursece4less.com nursece4less.com 2 Course Purpose To provide health clinicians with the fundamental knowledge and skills to promote healthy pregnancies, as well as basic concepts that should be well understood by healthcare professionals involved with the perinatal care of expectant mothers exposed to environmental stressors and possibly substance use. Target Audience Advanced Practice Registered Nurses and Registered Nurses (Interdisciplinary Health Team Members, including Vocational Nurses and Medical Assistants may obtain a Certificate of Completion) Course Author & Planning Team Conflict of Interest Disclosures Jassin M. Jouria, MD, William S. Cook, PhD, Douglas Lawrence, MA, Susan DePasquale, MSN, FPMHNP-BC – all have no disclosures. Acknowledgement of Commercial Support There is no commercial support for this course. Please take time to complete a self-assessment of knowledge, on page 4, sample questions before reading the article. Opportunity to complete a self-assessment of knowledge learned will be provided at the end of the course. nursece4less.com nursece4less.com nursece4less.com nursece4less.com 3 1. During pregnancy, the issues associated with alcohol are best stated as follows: a. each trimester is affected the same by alcohol consumption. b. alcohol consumption is safest during the first trimester. c. consuming alcohol only causes mild behavioral changes. d. there is no safe amount of alcohol. 2. Signs and symptoms of fetal alcohol syndrome in the neonate include: a. heart defects. b. small and narrow eyes. c. smooth upper lip. d. All of the above. 3. The chemical substance, cotinine, is detectable in patient’s urine for __________ following cigarette use. a. 3 to 5 days b. for a month c. for 24 hours d. up to ten days 4. The fetus of a smoking mother is more likely to develop a. congenital malformations. b. preeclampsia. c. diabetes. d. Chadwick’s sign. 5. True or False: According to the American College of Obstetrics and Gynecology, women should be screened for tobacco use at their initial prenatal appointment on a case-by-case basis. a. True b. False nursece4less.com nursece4less.com nursece4less.com nursece4less.com 4 Introduction Substance use during pregnancy is not uncommon. Pregnant women have been found to consume alcohol during the first trimester of pregnancy, and both illicit and prescription drug use have become a public health concern for women during pregnancy. Fetal exposure to substances affects normal fetal development and is associated with a high rate of low birth weight and childhood development and cognitive impairment. Health professionals must approach the subject of substance use during prenatal visits in a careful manner and from a position of being nonjudgmental and of providing unconditional support. The Prenatal Visits During prenatal visits the health clinician should identify unvoiced needs of the prenatal patient. Utilizing therapeutic communication to discuss these sensitive issues with women during pregnancy is essential when trying to understand their perspective and obstacles. Some commonly unvoiced needs are associated with lack of a support system, domestic abuse, depression, substance use and malnourishment. Malnourishment, may include weight loss, inability to gain weight, or reported consumption of processed foods low in nutritional value. Lack of a support system is linked to postpartum depression,1 a serious mental health issue that can affect recovery following birth and maternal-infant bonding. A lack of support during pregnancy also correlates with depression in pregnancy and difficulty with labor and breastfeeding in the postpartum phase.2 nursece4less.com nursece4less.com nursece4less.com nursece4less.com 5 Depression can affect the developing fetus leading to low birth weight, pre-term delivery and even cognitive abnormalities. Many women feel ashamed of their depression and will not report their feelings of sadness, lethargy, or anhedonia to their health team. Clinicians should evaluate the prenatal clients’ emotional state during every follow-up. Substance use is fairly common during pregnancy. In fact, a national survey found that 18 % of pregnant women drank alcohol during their first trimester.3 The number of women using opioid medication reportedly was increased; nearly 25 % of women of childbearing age used opioid medications every year.4 Such statistics confirm the important need for clinicians to delicately approach the subject of substance use and addiction with pregnant women during prenatal visits, and from a position of total support. The risk of physical abuse is increased for pregnant women, an alarming fact that all health team members should be monitoring during prenatal visits. Unexplained bruising, depression and late initiation of prenatal care should be a warning sign that physical abuse may be occurring. In addition to these considerations, other needs may need to be identified later on during the prenatal visit. Education on normal and abnormal pregnancy symptoms, as well as what symptoms require a phone call to the physician or a trip to the emergency room should be discussed. Signs of labor and the process of labor should not be assumed knowledge and the clinician should review this with the patient before her delivery date. The pregnant woman and her spouse should also be encouraged to take a prenatal labor preparation course. nursece4less.com nursece4less.com nursece4less.com nursece4less.com 6 Lochia bleeding (bleeding in the postpartum phase) should be discussed. Lochia that stops completely and then restarts or lochia that is getting heavier rather than lighter may require urgent intervention. Breastfeeding is also a common concern for pregnant mothers nearing their delivery date. Health staff should ask perinatal patients if they have any questions and ask what they know about breastfeeding. Some women should be prompted to attend breastfeeding courses or schedule an appointment with a lactation consultant. Many mothers worry about returning to work after the birth of their child. Prenatal clients should be asked about their plans and given resources and support for ideas if they are unsure about daycare or the ability to cope with leaving their infant. Substance Use And Early Identification The main theme of this section is the early identification of substance use in pregnant women, which can often be a difficult topic to approach during a
Recommended publications
  • FDA Guidance on Establishing Pregnancy Exposure Registries

    FDA Guidance on Establishing Pregnancy Exposure Registries

    Guidance for Industry Establishing Pregnancy Exposure Registries U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) August 2002 Clinical/Medical Guidance for Industry Establishing Pregnancy Exposure Registries Additional copies are available from: Office of Training and Communications Division of Communications Management Drug Information Branch, HFD-210 5600 Fishers Lane Rockville, MD 20857 (Tel) 301-827-4573 http://www.fda.gov/cder/guidance/index.htm or Office of Communication, Training, and Manufacturers Assistance (HFM-40) Center for Biologics Evaluation and Research (CBER) 1401 Rockville Pike, Rockville, MD 20852-1448 http://www.fda.gov/cber/guidelines.htm (Fax) 888-CBERFAX or 301-827-3844 (Voice Information) 800-835-4709 or 301-827-1800 U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) August 2002 Clinical/Medical TABLE OF CONTENTS I. INTRODUCTION................................................................................................................. 1 II. BACKGROUND ...................................................................................................................1 III. WHAT IS A PREGNANCY EXPOSURE REGISTRY? .................................................. 2 IV. WHAT MEDICAL PRODUCTS MAKE GOOD REGISTRY CANDIDATES?........... 3 V. WHEN SHOULD SUCH A REGISTRY BE ESTABLISHED?......................................
  • Running Head: BREASTFEEDING SUPPORT 1 Virtual Lactation

    Running Head: BREASTFEEDING SUPPORT 1 Virtual Lactation

    Running Head: BREASTFEEDING SUPPORT 1 Virtual Lactation Support for Breastfeeding Mothers During the Early Postpartum Period Shakeema S. Jordan College of Nursing, East Carolina University Doctor of Nursing Practice Program Dr. Tracey Bell April 30, 2021 Running Head: BREASTFEEDING SUPPORT 2 Notes from the Author I want to express a sincere thank you to Ivy Bagley, MSN, FNP-C, IBCLC for your expertise, support, and time. I also would like to send a special thank you to Dr. Tracey Bell for your support and mentorship. I dedicate my work to my family and friends. I want to send a special thank you to my husband, Barry Jordan, for your support and my two children, Keith and Bryce, for keeping me motivated and encouraged throughout the entire doctorate program. I also dedicate this project to many family members and friends who have supported me throughout the process. I will always appreciate all you have done. Through my personal story and the doctorate program journey, I have learned the importance of breastfeeding self-efficacy and advocacy. I understand the impact an adequate support system, education, and resources can have on your ability to reach your individualized breastfeeding goals. Running Head: BREASTFEEDING SUPPORT 3 Abstract Breastmilk is the clinical gold standard for infant feeding and nutrition. Although maternal and child health benefits are associated with breastfeeding, national, state, and local rates remain below target. In fact, 60% of mothers do not breastfeed for as long as intended. During the early postpartum period, mothers cease breastfeeding earlier than planned due to common barriers such as lack of suckling, nipple rejection, painful breast or nipples, latching or positioning difficulties, and nursing demands.
  • Breastfeeding Guide Lactation Services Department Breastfeeding: Off to a Great Start

    Breastfeeding Guide Lactation Services Department Breastfeeding: Off to a Great Start

    Breastfeeding Guide Lactation Services Department Breastfeeding: Off to a Great Start Offer to feed your baby: • when you see and hear behaviors that signal readiness to feed. Fussiness and hand to mouth motions may signal hunger. At other times, your baby is asking to be held or changed. He may be showing signs of being over-stimulated or tired. • until satisfied. In the early weeks and months, feeding lengths vary from 10 to 40 minutes per side. Offer both breasts at each feeding. Your baby may not always take the second side. Expect your baby to cluster feed to increase your milk supply, especially when going through growth spurts. • at least every 1 ½ to 3 hours during the day and a little less frequently at night. Time feedings from the start of one feeding to the start of the next. Most mothers are able to produce enough milk and do NOT need to supplement with formula. • using proper positioning. Turn your baby toward you while breastfeeding. With a wide open mouth, she takes in the areola along with the nipple. The cheeks and chin are touching the breast. Expect your baby to pause between suckle bursts. It is okay to gently stimulate her to suckle throughout the feeding. Your baby is getting enough breastmilk IF: • you hear audible swallows when your baby pauses between suckle bursts. You will hear them more often as your milk changes 24 Hours from colostrum to mature milk. st at least 6 feedings • there are 6 or more wet diapers by day 6. This number will 1 1 wet and 1 stool remain fairly constant after the first week.
  • Australian Product Information – Panadol Night (Paracetamol 500Mg, Diphenhydramine Hydrochloride 25Mg) Tablets

    Australian Product Information – Panadol Night (Paracetamol 500Mg, Diphenhydramine Hydrochloride 25Mg) Tablets

    AUSTRALIAN PRODUCT INFORMATION – PANADOL NIGHT (PARACETAMOL 500MG, DIPHENHYDRAMINE HYDROCHLORIDE 25MG) TABLETS 1 PANADOL NIGHT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: Paracetamol Contains: potassium sorbate as preservative Excipients: For full list of excipients, see section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Panadol Night is a film coated, blue caplet (capsule shaped tablet) with “PANADOL” printed on one face and “NIGHT” on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the temporary relief of pain when associated with sleeping difficulty, for example: headache, migraine, backache, arthritis, rheumatic and muscle pain, neuralgia, toothache or period pain. Relief of fever. 4.2 DOSE AND METHOD OF ADMINISTRATION Adults and children over 12 years: take 1 - 2 tablets with water or other fluid only at bedtime. Maximum of two tablets in 24 hours. Do not exceed the stated dose. Do not use in children under 12 years of age. Other products containing paracetamol may be taken during the day but the total daily dose of paracetamol must not exceed 4,000 mg in any 24 hour period. Allow at least four hours between taking any paracetamol-containing product and Panadol Night. For adults, paracetamol should not be taken for more than a few days at a time except on medical advice. For children, paracetamol should not be taken for more than 48 hours except on medical advice. Do not exceed the stated dose. To be taken at bedtime. Should not be used with other anti-histamine containing preparations, including those used on the skin (see Warnings and Precautions). The lowest dose necessary to achieve efficacy should be used for the shortest duration of treatment.
  • 00005721-201907000-00003.Pdf

    00005721-201907000-00003.Pdf

    2.0 ANCC Contact Hours Angela Y. Stanley, DNP, APRN-BC, PHCNS-BC, NEA-BC, RNC-OB, C-EFM, Catherine O. Durham, DNP, FNP-BC, James J. Sterrett, PharmD, BCPS, CDE, and Jerrol B. Wallace, DNP, MSN, CRNA SAFETY OF Over-the-Counter MEDICATIONS IN PREGNANCY Abstract Approximately 90% of pregnant women use medications while they are pregnant including both over-the-counter (OTC) and prescription medications. Some medica- tions can pose a threat to the pregnant woman and fetus with 10% of all birth defects directly linked to medications taken during pregnancy. Many medications have docu- mented safety for use during pregnancy, but research is limited due to ethical concerns of exposing the fetus to potential risks. Much of the information gleaned about safety in pregnancy is collected from registries, case studies and reports, animal studies, and outcomes management of pregnant women. Common OTC categories of readily accessible medications include antipyretics, analgesics, nonsteroidal anti- infl ammatory drugs, nasal topicals, antihistamines, decongestants, expectorants, antacids, antidiar- rheal, and topical dermatological medications. We review the safety categories for medications related to pregnancy and provide an overview of OTC medications a pregnant woman may consider for management of common conditions. Key words: Pharmacology; Pregnancy; Safety; Self-medication. Shutterstock 196 volume 44 | number 4 July/August 2019 Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. he increased prevalence of pregnant women identifi ed risks in animal-reproduction studies or completed taking medications, including over-the-counter animal studies show no harm. The assignment of Category (OTC) medications presents a challenge to C has two indications; (1) limited or no research has been nurses providing care to women of childbear- conducted about use in pregnancy, and (2) animal studies ing age.
  • Registration

    Registration

    Location Registration REGISTRATION Please register early! San Diego County Midwives Our format includes the required three hours of 15644 Pomerado Road, S-302 lactation training to assist you in completing your Name Poway, CA 92064 DONA Certification. Address 858.278.2930 Complete this registration form and submit the Parking is available in front, come right in. We full amount or a $250 deposit to reserve a spot in City/State/Zip look forward to seeing you soon! Occasionally, a the workshop (balance due by the first meeting). change of venue is necessary. Please check Registration postmarked ONE week prior to Phone emails regularly course will be only $475. Late registration (on a Email Meals, snacks, beverages space available basis) is possible, for an additional fee of $40. Profession You may bring lunches and dinner for yourself Important Cancellation Information: If (refrigerator & microwave available) or there are cancellation is received in writing by one week Any birth experiences? many eating establishments nearby. prior to workshop, a full refund less a $50.00 Payment Methods: administrative fee will be refunded. After that • Stripe, CashApp or PayPal – if you would Please bring something to share on Saturday and time, no refunds will be given; however, you may like to use this option, let Lisa know and a Sunday with your fellow doula students. designate a substitute to use your registration or request for payment will be sent to you. transfer it to another training within 1 year of the • Check/money order payable to Gerri Ryan For further information: cancelled training. can be sent to Lisa’s address below: • Lisa – 619-988-3911 call/text or Lisa Simpkins [email protected] Workshop Preparation 825 W Beech Street, #104, San Diego, CA 92101 • Gerri – I.
  • The Empire Plan SEPTEMBER 2018 REPORTING ON

    The Empire Plan SEPTEMBER 2018 REPORTING ON

    The Empire Plan SEPTEMBER 2018 REPORTING ON PRENATAL CARE Every baby deserves a healthy beginning and you can take steps before your baby is even born to help ensure a great start for your infant. That’s why The Empire Plan offers mother and baby the coverage you need. When your primary coverage is The Empire Plan, the Empire Plan Future Moms Program provides you with special services. For Empire Plan enrollees and for their enrolled dependents, COBRA enrollees with their Empire Plan benefits and Young Adult Option enrollees TABLE OF CONTENTS Five Important Steps ........................................ 2 Feeding Your Baby ...........................................11 Take Action to Be Healthy; Breastfeeding and Your Early Pregnancy ................................................. 4 Empire Plan Benefits .......................................12 Prenatal Testing ................................................. 5 Choosing Your Baby’s Doctor; New Parents ......................................................13 Future Moms Program ......................................7 Extended Care: Medical Case High Risk Pregnancy Program; Management; Questions & Answers ...........14 Exercise During Pregnancy ............................ 8 Postpartum Depression .................................. 17 Your Healthy Diet During Pregnancy; Medications and Pregnancy ........................... 9 Health Care Spending Account ....................19 Skincare Products to Avoid; Resources ..........................................................20 Childbirth Education
  • Prenatal Breastfeeding Education and Counseling Toolkit

    Prenatal Breastfeeding Education and Counseling Toolkit

    Acknowledgements The Knox County Health Department would like to thank the University of Tennessee Medical Center Regional Perinatal Program and the University of Tennessee Public Health Nutrition Program for their contributions to the development and distribution of this toolkit. This project is funded under a grant contract with the State of Tennessee. Table of Contents Introduction …………………………………………………………………………………………………….…3 Well Woman Care …………………………………………………………………………………………….. 5 First Trimester ………………………………………………………………………………………………….. 6 Second Trimester …………………………………………………………………………………….……….. 8 Third Trimester …………………………………………………………………………….…………………. 11 Six Weeks Postpartum ……………………………………………………………………….……………..15 Frequently Asked Questions ……………………………………………………………………………..19 Additional Resources ………………………………………………………………………………………..21 References ………………………………………………………………………………………..……………. 22 Appendix A: Breastfeeding Screening Tool..……………………………………………………….24 Appendix B: Prenatal Infographics …………………………………………………………………….26 1 Introduction It’s well-established that breastfeeding is the healthiest method of infant feeding. Breastfed infants are less likely to develop respiratory and ear infections, allergies, asthma, obesity, diabetes and childhood cancers. For mothers, breastfeeding reduces the risk of type 2 diabetes; breast, ovarian and cervical cancers; and postpartum depression. These are just a few of the numerous health benefits of breastfeeding. Many national health organizations including the American Congress of Obstetrics and Gynecologists
  • Breastfeeding Your Baby: a Personalized

    Breastfeeding Your Baby: a Personalized

    Breastfeeding your baby General guidelines for breastfeeding a full-term, healthy baby This sheet goes over basic guidelines to The benefits of breast milk help you over the next weeks. Be sure to talk with your baby’s health care provider Breast milk is the ideal food for your baby. It has about feeding your baby. If you need help several advantages over formula: breastfeeding: . It is more easily digested than formula. In the hospital: . It contains a balance of nutrients that is ideal . Ask your nurse for help. for your baby. It contains antibodies and special cells that . Attend the breastfeeding class. help protect your baby from infections. The American Academy of Pediatrics Once you are at home recommends that full-term, healthy babies, . Call 617-667-5765 to leave a receive breast milk exclusively for at least the message for a BIDMC lactation first 6 months of life. Premature babies and consultant. those with medical problems should also receive breast milk as soon as possible after birth, with . Call your pediatric provider. or without supplements, according to each baby’s needs. Contact the resources listed on the back of this sheet. Remember: . Feed your baby at least 8-12 times every 24 Getting started hours. If your baby isn’t nursing well, call your health care provider. Rooming-in around the clock and . Keep a written feeding and diaper record. frequent skin-to-skin contact may (You will be given a form to use.) Notify your promote your baby’s readiness to baby’s health care provider if your baby is breastfeed.
  • Use of Prescribed Psychotropics During Pregnancy: a Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes

    Use of Prescribed Psychotropics During Pregnancy: a Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes

    brain sciences Review Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes Catherine E. Creeley * and Lisa K. Denton Department of Psychology, State University of New York at Fredonia, Fredonia, NY 14063 USA; [email protected] * Correspondence: [email protected]; Tel.: +1-716-673-3890 Received: 19 July 2019; Accepted: 9 September 2019; Published: 14 September 2019 Abstract: This paper reviews the findings from preclinical animal and human clinical research investigating maternal/fetal, neonatal, and child neurodevelopmental outcomes following prenatal exposure to psychotropic drugs. Evidence for the risks associated with prenatal exposure was examined, including teratogenicity, neurodevelopmental effects, neonatal toxicity, and long-term neurobehavioral consequences (i.e., behavioral teratogenicity). We conducted a comprehensive review of the recent results and conclusions of original research and reviews, respectively, which have investigated the short- and long-term impact of drugs commonly prescribed to pregnant women for psychological disorders, including mood, anxiety, and sleep disorders. Because mental illness in the mother is not a benign event, and may itself pose significant risks to both mother and child, simply discontinuing or avoiding medication use during pregnancy may not be possible. Therefore, prenatal exposure to psychotropic drugs is a major public health concern. Decisions regarding drug choice, dose, and duration should be made carefully, by balancing severity, chronicity, and co-morbidity of the mental illness, disorder, or condition against the potential risk for adverse outcomes due to drug exposure. Globally, maternal mental health problems are considered as a major public health challenge, which requires a stronger focus on mental health services that will benefit both mother and child.
  • IBCLC: the Documented Difference

    IBCLC: the Documented Difference

    United States Lactation Consultant Association 202.738.1125 • Washington, D.C. www.uslca.org • [email protected] USLCA United States Lactation Consultant Association IBCLC: The Documented Difference Brent NB, et al. Breast-feeding in a low-income population. Program to increase incidence and duration. Arch Pediatr Adolesc Med 1995; 149:798-803. Individual prenatal lactation consultation by IBCLCs, Andaya E, et al. Perceptions of primary care-based breastfeeding daily rounds by the lactation consultant on the postpartum promotion interventions: qualitative analysis of randomized unit, and outpatient follow-up at 48 hours after discharge, controlled trial participant interviews. Breastfeed Med at the time that the infant was 1 week of age, and at all 2012;7:417-422. future health supervision visits for infants up to 1 year of age resulted in an increased incidence and duration of Exposure to IBCLC prenatal education and early breastfeeding in a low income population. postpartum intervention resulted in the prevention of exclusive formula feeding, improved duration of breastfeeding, and Castrucci B, et al. A comparison of breastfeeding rates in an interventions that reduced the incidence of low milk supply. urban birth cohort among women delivering infants at hospitals that employ and do not employ lactation consultants. J Public Bonuck, KA, et al. Effect of primary care intervention on Health Management Practice 2006;12:578-585 breastfeeding duration and intensity. Am J Public Health 2014; 104 (Suppl 1): S119-S127. Delivering in a hospital that employed an IBCLC lactation consultant resulted in a 2.28 times increase in the A key strategy for increasing the duration and odds of breastfeeding at hospital discharge.
  • The CDC Guide to Breastfeeding Interventions

    The CDC Guide to Breastfeeding Interventions

    U.S. Department of Health and Human Services Katherine R. Shealy, MPH, IBCLC, RLC Ruowei Li, MD, PhD Sandra Benton-Davis, RD, LD Laurence M. Grummer-Strawn, PhD U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Division of Nutrition and Physical Activity Acknowledgments We gratefully acknowledge and thank all contributors and reviewers of The CDC Guide to Breastfeeding Interventions. The efforts of Jane Heinig, PhD, IBCLC, RLC, Deborah Galuska, PhD, Diana Toomer, Barbara Latham, RD, LD, Carol MacGowan, MPH, RD, LD, Robin Hamre, MPH, RD, and members of the CDC Obesity Team helped make this document possible. Publication Support was provided by Palladian Partners, Inc., under Contract No. 200-980-0415 for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Photographs contained in this guide were purchased solely for educational purposes and may not be reproduced for commercial use. Recommended Citation Shealy KR, Li R, Benton-Davis S, Grummer-Strawn LM. The CDC Guide to Breastfeeding Interventions. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2005. For more information or to download this document or sections of this document, please visit http://www.cdc.gov/breastfeeding To request additional copies of this document, please email your request to [email protected] or write to us at the following address and request The CDC Guide to Breastfeeding Interventions: Maternal and Child Nutrition Branch, Division of Nutrition and Physical Activity National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention 4770 Buford Highway, NE Mailstop K–25 Atlanta, Georgia 30341-3717 Contents Introduction Introduction .